Role of peritoneal dialysis as a chronic renal replacement therapy in cardiorenal patients

Contributions to Nephrology

Volumn 178, Issue , 2012, Pages 182-188

  Pego, C ^a   Rodrigues, A ^a   Ronco, C ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925756443     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000337850     Document Type: Article

References (31)

1. House AA, Anand I, Bellomo R, et al: Workgroup statements the 7th ADQI Consensus Conference. Nephrol Dial Transplant 2010;25:1416- 1420.
2. Ronco C, et al: Cardiorrenal syndrome: refining the definition of a complex symbiosis gone wrong. Intens Care Med 2008;34:957- 962.
3. Adams KF Jr, Fonarow GC, Emerman CL, et al: Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149:209- 216.
4. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ: Risk stratification for in- hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293:572- 580.
5. Hillege HL, Nitsch D, Pfeffer MA, et al: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113:671- 678.
6. Costanzo MR, Guglin M, Saltzberg M: Ultrafiltration is associated with fewer re- hospitalizations than continuous diuretic infusion in patient with decompensated heart failure: results from UNLOAD. J Am Coll Cardiol 2007;49:675- 683.
7. Montejo JD, Bajo MA, del Peso G, Selgas R: Papel de la diálisis peritoneal en el tratamiento de la insuficiencia cardíaca refractaria. Nefrologia 2010;30:21- 27.
8. Sanchez JE, Ortega T, Rodriguez C, Diaz-Molina B, Martín M, Garcia-Cueto C, Vidau P, Gago E, Ortega F: Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 2010;25:605- 610.
9. Gotloib L, Fudin R, Yakubovich M, Vienken J: Peritoneal dialysis in refractory end- stage congestive heart failure: a challenge facing a no- win situation. Nephrol Dial Transplant 2005;20(suppl 7):vii32.
10. Bertoli SV, Ciurlino D, Maccario M, Martino S, Bigatti G, Traversi L, Procaccio M, Buzzi L: Home peritoneal ultrafiltration in patients with severe congestive heart failure without end- stage renal disease. Adv Perit Dial 2005;21:123- 127.
11. Van Biesen W, Verbeke F, Vanholder R: Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant 2007;22:53- 58.
12. Qi H, Xu C, Yan H, Ma J: Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta- analysis of randomized controlled trials. Perit Dial Int 2011;31:179- 188.
13. Paniagua R, Ventura MD, Avila-Díaz M, Cisneros A, Vicenté-Martínez M, Furlong MD, García-González Z, Villanueva D, Orihuela O, Prado-Uribe MD, Alcántara G, Amato D: Icodextrin improves metabolic and fluid management in high and highaverage transport diabetic patients. Perit Dial Int 2009;29:422- 432.
14. Basile C, Chimienti D, Bruno A, Cocola S, Libutti P, Teutonico A, Cazzato F: Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure. Perit Dial Int 2009;29:116.
15. Sav T, Inanc MT, Dogan A, Oymak O, Utas C: Two daytime icodextrin exchanges decrease brain natriuretic peptide levels and improve cardiac functions in continuous ambulatory peritoneal dialysis patients. Nephrology (Carlton) 2010;15:307- 312.
16. Sav T, Oymak O, Inanc MT, Dogan A, Tokgoz B, Utas C: Effects of twicedaily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2009;29:443- 449.
17. Cnossen N, Kooman JP, Konings CJ, et al: Peritoneal dialysis in patients with congestive heart failure. Nephrol Dial Transplant 2006;21(suppl 2):ii63- ii66.
18. McIntyre CW: Recurrent circulatory stress: the dark side of dialysis. Semin Dial 2010;23:449- 451.
19. Breidthardt T, McIntyre CW: Dialysisinduced myocardial stunning: the other side of the cardiorenal syndrome. Rev Cardiovasc Med 2011;12:13- 20.
20. Selby NM, McIntyre CW: Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int 2011;31:27- 33.
21. Ritz E: Intestinal- renal syndrome: mirage or reality? Blood Purif 2011;31:70- 76.
22. McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK: Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011;6:133- 41.
23. Jefferies HJ, Virk B, Schiller B, Moran J, McIntyre CW: Frequent hemodialysis schedules are associated with reduced levels of dialysis- induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 2011;6:1326- 1332.
24. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B: Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003;64:1071- 1079.
25. Sens F, Schott-Pethelaz AM: Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end- stage renal disease and congestive heart failure. Kidney Int 2011;80:970-977.
26. Stack AG, Mohammed A, Hanley A, Mutwali A, Nguyen H: Survival trends of US dialysis patients with heart failure: 1995 to 2005. Clin J Am Soc Nephrol 2011;6:1982- 1989.
27. Ronco C, Kaushik M, Valle R, Aspromonte N, Peacock WF: Diagnosis and management of fluid overload in heart failure and cardiorenal syndrome: the '5B' approach. Semin Nephrol 2012;32:129- 141.
28. Devolder I, Verleysen A, Vijt D, Vanholder R, Van Biesen W: Body composition, hydration and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 2010;30:208- 214.
29. John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ: Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol 2010;5:1463- 1470.
30. Davies S, Carlsson O, Simonsen O, Johansson AC, Venturoli D, Ledebo I, Wieslander A, Chan C, Rippe B: The effects of low- sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant 2009;24:1609- 1617.
31. Freida P, Issad B, Dratwa M, Lobbedez T, Wu L, Leypoldt JK, Divino-Filho JC: A combined crystalloid and colloid pd solution as a glucose- sparing strategy for volume control in high- transport apd patients: a prospective multicenter study. Perit Dial Int 2009;29:433- 442.